Zhong Guo Jing Ji Wang·2025-11-28 03:33Core Viewpoint - Nearshore Protein (688137.SH) announced a share reduction plan by shareholders holding less than 5% of the company's shares, citing operational development and funding needs as the reason for the reduction [1] Shareholder Reduction Plans - Nanjing Jinliang plans to reduce up to 13,735 shares, representing a maximum of 0.0196% of total shares, through centralized bidding [2] - Suzhou Jinling intends to reduce up to 15,376 shares, also representing a maximum of 0.0219%, via centralized bidding and block trading [4] - Shanghai Pujin plans to reduce up to 111,000 shares, accounting for a maximum of 0.1582%, through centralized bidding and block trading [4] Reduction Period and Source - The reduction period for all shareholders is set from December 4, 2025, to March 3, 2026 [3][4] - All shares to be reduced were acquired prior to the IPO [3][4] IPO and Fundraising Details - Nearshore Protein was listed on the Shanghai Stock Exchange's Sci-Tech Innovation Board on September 29, 2022, with an issue price of 106.19 yuan per share and a total issuance of 17.54386 million shares [4] - The total amount raised from the IPO was 1.8629825 billion yuan, with a net amount of 1.7421958 billion yuan after deducting issuance costs, exceeding the original plan by 242.1958 million yuan [5] - The funds raised are intended for projects related to diagnostic core materials, innovative diagnostic reagent industrialization, R&D center construction, and working capital supplementation [5]